Lamivudine
Showing 1 - 25 of 885
Retinal Detachment, Rhegmatogenous Retinal Detachment Trial in Madison (Lamivudine 300 MG, Placebo)
Not yet recruiting
- Retinal Detachment
- Rhegmatogenous Retinal Detachment
- Lamivudine 300 MG
- Placebo
-
Madison, WisconsinUniversity of Wisconsin
Sep 20, 2023
Abacavir and Lamivudine Anabolites
Completed
- HIV-1-infection
- Blood collection
- +3 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 5, 2023
Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)
Active, not recruiting
- Hiv
- HIV-1-infection
- Lamivudine 300 MG
- Emtricitabine / Tenofovir Disoproxil Pill
-
Buenos Aires, ArgentinaFundacion IDEAA
Jan 2, 2023
AIDS Trial (Dolutegravir 50 MG plus lamivudine 300 MG; Dolutegravir/lamivudine (50 MG/300 MG))
Not yet recruiting
- Acquired Immunodeficiency Syndrome
- Dolutegravir 50 MG plus lamivudine 300 MG; Dolutegravir/lamivudine (50 MG/300 MG)
- (no location specified)
Aug 6, 2022
HIV Trial in Liège (Treatment simplification (dolutegravir lamivudine))
Active, not recruiting
- HIV Infections
- Treatment simplification (dolutegravir lamivudine)
-
Liège, BelgiumLiège university hospital
Apr 27, 2022
Lamivudine and Dotiravir Sodium Tablets in Treatment-naïve HIV-1
Not yet recruiting
- HIV-1-infection
- Lamivudine and Dotiravir Sodium Tablets
- (no location specified)
Apr 10, 2022
HIV Trial in Spain (Dolutegravir 50 MG / Lamivudine 300 MG Oral Tablet [Dovato])
Active, not recruiting
- HIV Infections
- Dolutegravir 50 MG / Lamivudine 300 MG Oral Tablet [Dovato]
-
Vigo, Pontevedra, Spain
- +16 more
Jun 20, 2022
HIV I Infection Trial in Orlando (Dolutegravir / Lamivudine Pill, Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill)
Active, not recruiting
- HIV I Infection
- Dolutegravir / Lamivudine Pill
- Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill
-
Orlando, FloridaOrlando Immunology Center
Sep 20, 2022
HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease
Active, not recruiting
- HIV-1 Infection
- Doravirine, Tenofovir, Lamivudine
- +4 more
- (no location specified)
Sep 2, 2022
Human Immunodeficiency Virus (HIV) Trial (Doravirine, Tenofovir, Lamivudine, ATRIPLA™, Placebo)
Active, not recruiting
- Human Immunodeficiency Virus (HIV)
- Doravirine, Tenofovir, Lamivudine
- +2 more
- (no location specified)
Sep 1, 2022
HIV-1-infection Trial in Argentina, Brazil (Intervention Arm: dolutegravir/lamivudine, Comparator ARM: TDF/XTC plus Dolutegravir
Recruiting
- HIV-1-infection
- Intervention Arm: dolutegravir/lamivudine
- Comparator ARM: TDF/XTC plus Dolutegravir (XTC stand for lamivudine OR emtricitabine)
-
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
- +7 more
Jun 29, 2022
HIV-1-infection Trial in Montréal (abacavir, dolutegravir and lamivudine dispersible tablets, Triumeq Dispersible Tablets 5 mg
Completed
- HIV-1-infection
- abacavir, dolutegravir and lamivudine dispersible tablets
- Triumeq Dispersible Tablets 5 mg GSK1349572 [Dolutegravir]/ 60 mg Abacavir/ 30 mg Lamivudine
-
Montréal, Quebec, CanadaAltasciences
Mar 10, 2022
HIV-1 Infection Trial in Caba, Rosario (Dolutegravir plus lamivudine)
Withdrawn
- HIV-1 Infection
- Dolutegravir plus lamivudine
-
Caba, Buenos Aires, Argentina
- +1 more
Apr 5, 2022
Aicardi-Goutières Syndrome Trial in Edinburgh (Abacavir (ABC), Lamivudine (3TC), Abacavir (ABC)+Lamivudine (3TC)+Zidovudine
Recruiting
- Aicardi-Goutières Syndrome
- Abacavir (ABC)
- +2 more
-
Edinburgh, United KingdomYanick Crow
Aug 26, 2022
Chronic Hepatitis B Trial (Adefovir Dipivoxil)
Completed
- Chronic Hepatitis B
- Adefovir Dipivoxil
- (no location specified)
Nov 5, 2021
Hiv Trial in France (Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO])
Not yet recruiting
- Hiv
- Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]
-
Caen, France
- +3 more
Sep 6, 2023
HIV Trial (Influenza Virus Vaccine, Pneumococcal Vaccine, Polyvalent (23-valent), Lamivudine)
Withdrawn
- HIV Infections
- Influenza Virus Vaccine
- +2 more
- (no location specified)
Oct 28, 2021
Hiv, Weight Gain Trial in Toronto (DOR/3TC/TDF)
Enrolling by invitation
- Hiv
- Weight Gain
-
Toronto, Ontario, CanadaUniversity Health Network
May 17, 2022
Extensive Stage Lung Small Cell Carcinoma Trial in Buffalo (Atezolizumab, Carboplatin, Etoposide)
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Atezolizumab
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 9, 2022
Colorectal Cancer Metastatic Trial in Boston (Lamivudine)
Active, not recruiting
- Colorectal Cancer Metastatic
- Lamivudine
-
Boston, MassachusettsMassachusetts general Hospital
Aug 25, 2021
HTLV-I-associated Myelopathy Trial in London (Zidovudine/lamivudine, Placebos)
Completed
- HTLV-I-associated Myelopathy
- Zidovudine/lamivudine
- Placebos
-
London, United KingdomImperial College
Aug 24, 2021